Vectron Biosolutions AS is your expert on developing cost-effective microbial production processes for recombinant proteins

Do you need to cut manufacturing costs?

The manufacturing costs of many recombinant proteins can be significantly reduced through increasing titres and improving the solubility of the proteins, reducing the necessities of costly downstream processes. This is increasingly important in the competitive landscape of the biopharmaceutical industry, especially with the advent of biosimilars and biobetters, as well as for suppliers of industrial enzymes where the markets are smaller.

Vectron Biosolutions is your upstream expert on developing robust, cost-efficient production processes for recombinant proteins in E. coli and other bacteria. We have proprietary next-generation expression tools and decades of experience that is available to you through partnerships and licensing.

Latest news

  • Vectron to the finale in DNB Healtcare Prize 2016!

    November 21 | 2016

    Among 12 companies selected to pitch before the jury, Vectron was one of 6 companies who made it to the finale on December 15.

  • Semifinal DNB Healthcare Prize 2016

    November 11 | 2016

    Vectron to reach the semifinal and compete for NOK 1 million!

    Read more
  • Vectron enters agreement with EnginZyme

    October 26 | 2016

    EnginZyme to use the VB technology for production of CalB.

    Read more
  • New job positions at Vectron

    October 25 | 2016

    Vectron needs more scientific colleagues and is currently looking to hire good candidates.

    Read about the positions here.
Complete newslist


  • BIOPROSP_17; Tromsø, Norway

    Mar 08–10 | 2017
  • BIO-Europe Spring; Barcelona, Spain

    Mar 20–22 | 2017
  • 9th International Conference on Recombinant Protein Production; Dubrovnik, Croatia

    Apr 23–25 | 2017
  • BIO International Convention; San Diego, CA, USA

    Jun 19–22 | 2017
Meet us there!
More events